RAM
ANVS icon

Redmond Asset Management’s Annovis Bio ANVS Stock Holding History

Redmond Asset Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-36,157
Closed -$430K – 156
2024
Q1 		$430K Buy
36,157
+2,077
+6% +$22.7K 0.14% 126
2023
Q4 		$637K Hold
34,080
– – 0.21% 116
2023
Q3 		$323K Buy
34,080
+70
+0.2% +$866 0.12% 136
2023
Q2 		$486K Hold
34,010
– – 0.16% 125
2023
Q1 		$524K Hold
34,010
– – 0.18% 127
2022
Q4 		$457K Buy
+34,010
New +$425K 0.16% 132
2021
Q4 		– Sell
-7,878
Closed -$250K – 198
2021
Q3 		$250K Buy
7,878
+128
+2% +$7.36K 0.08% 174
2021
Q2 		$663K Buy
+7,750
New +$358K 0.19% 142

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.29B AUM 21.04% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Redmond Asset Management's ANVS Position: Q2 2024 in Review

Redmond Asset Management sold out of Annovis Bio (ANVS) in Q2 2024, closing a stake of 36,157 shares — an estimated $430K sold.

Redmond Asset Management first reported a position in ANVS in Q2 2021 and held it in 8 quarters. The position peaked at $663K in Q2 2021. 31 funds tracked by Wall St. Rank hold ANVS as of Q2 2024.

  • Redmond Asset Management reported no remaining Annovis Bio position as of Q2 2024 after selling out during the quarter.
  • Redmond Asset Management sold 36,157 Annovis Bio shares in Q2 2024, an estimated $430K.
  • Redmond Asset Management first reported a position in Annovis Bio in Q2 2021 and held it in 8 quarters.
  • Redmond Asset Management's Annovis Bio position peaked at $663K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2024.

Based on Redmond Asset Management's 13F filing for Q2 2024, filed 9 Aug 2024.